AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,460.00p
   
  • Change Today:
    -248.00p
  • 52 Week High: 15,316.00
  • 52 Week Low: 10,956.00
  • Currency: UK Pounds
  • Shares Issued: 1,551.03m
  • Volume: 3,963,823
  • Market Cap: £177,748m
  • RiskGrade: 123
  • Beta: 0.00

Key dates

Dividend  
Latest XD Date (1st Interim) 06-Aug-2026
Latest Pay Date (1st Interim) 08-Sep-2026
   
Meetings  
AGM 09-Apr-2026
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 10-Feb-2026
Interim results 27-Jul-2026
Q1 Results 29-Apr-2026
Q2 Results 27-Jul-2026
Q3 Results 06-Nov-2025
Q4 Results 10-Feb-2026
Annual Report 24-Feb-2026
   
Year End n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,460.00p
Change Today -248.00p
% Change -2.12 %
52 Week High 15,316.00
52 Week Low 10,956.00
Volume 3,963,823
Shares Issued 1,551.03m
Market Cap £177,748m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 06-Aug-26 19-Feb-26
Paid 08-Sep-26 23-Mar-26
Amount 106.00¢ 217.00¢

Trades for 14-Aug-2026

Time Volume / Share Price
17:15 103,894 @ 11,610.00p
17:15 103,894 @ 11,610.00p
17:15 103,894 @ 11,610.00p
15:38 312,000 @ 11,610.00p
13:25 353,938 @ 11,610.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page